Abaperidone
Alternative Names: FI-8602Latest Information Update: 04 Nov 2017
Price :
$50 *
At a glance
- Originator Ferrer
- Class Antipsychotics
- Mechanism of Action Dopamine D2 receptor antagonists; Serotonin 5-HT2A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Schizophrenia in Spain (PO)
- 28 Jun 2006 Clinical trials in Schizophrenia (PO)
- 05 Jan 2004 No development reported - Clinical-Phase-Unknown for Schizophrenia (unspecified route)